A.Performance of the predictor using a cross-validation strategy.
B.Performance of the Ig-mutational subtype predictor in a test set of 6 unmutated and 4 mutated CLL samples. See text for details.
|
|
|
Figure 3. Statistical methodology for the creation and validation of an Ig-mutational status predictor in CLL
A.Performance of the predictor using a cross-validation strategy. B.Performance of the Ig-mutational subtype predictor in a test set of 6 unmutated and 4 mutated CLL samples. See text for details. |